Lumos Pharma vs Ocugen
Ocugen
Approaching healthcare innovation with purpose and agility to deliver new breakthroughs for people facing disease
129 employees · est. 2013 · Malvern, United States
Lumos Pharma is the older company (1999 vs 2013); Ocugen is the larger of the two.
Side-by-Side Comparison
| Metric | Lumos Pharma | Ocugen |
|---|---|---|
| Founded | ||
| Founded | 1999 older | 2013 |
| Headquarters | ||
| Headquarters | Austin, United States | Malvern, United States |
| Employees | ||
| Employees | 47 | 129 larger |
| Industry | ||
| Industry | Biopharma, Biotechnology, Health Care | Not tracked yet |
| Funding Stage | ||
| Funding Stage | Series B | IPO |
| Total Funding | ||
| Total Funding | $53.50M | $201.82M |
| Funding Rounds | ||
| Funding Rounds | 3 | 11 |
| Services | ||
| Services | Development of therapeutics for rare diseases, Clinical trials for growth deficiencies, Patient advocacy and compassionate use | Development of Gene Therapies, Research and Development, Clinical Trial Management, Patient-Centric Solutions |
| Target Customers | ||
| Target Customers | Patients with rare diseases, Families dealing with growth deficiencies, Healthcare providers, Biopharmaceutical partners | Patients with Retinal Diseases, Healthcare Providers, Medical Researchers, Investors in Biotech Sector |
| Taxonomy | ||
| Taxonomy | BiopharmaceuticalClinical-stageRare DiseasesTherapeuticsPediatric Growth Hormone DeficiencyOral Growth Hormone Therapy +9 | Gene TherapyBlindness DiseasesOphthalmologyClinical-stage BiopharmaceuticalModifier Gene Therapy PlatformInherited Retinal Disorders +8 |
| Website | ||
| Website | lumos-pharma.com | ocugen.com |
About Lumos Pharma
Lumos Pharma, founded in 1999, is a clinical-stage biopharmaceutical company headquartered in the United States. Known for their slogan, "Transforming Lives with Rare Focus", the company is dedicated to developing new therapies for rare diseases, with a primary emphasis on high-need areas where ther...
About Ocugen
Ocugen, founded in 2013 and headquartered in the United States, is a biotechnology company dedicated to tackling major blindness diseases with innovative gene therapies. Through their unique modifier gene therapy platform, Ocugen aims to address the significant unmet needs of large patient populatio...
Also comparing in this category
Comparing more than these two?
Get Lumos Pharma, Ocugen and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.
How does Lumos Pharma compare?
A PDF of Lumos Pharma and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Frequently Asked Questions
Compare Lumos Pharma with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Lumos Pharma on 11 Mar 2026, and Ocugen on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
